撰文丨王聪 编辑丨王多鱼 排版丨水成文 Clinical Medicine Insights: Oncology 是 Sage 出版社旗下的一本国际化、同行评议的 开放获取期刊 （ Open Access Journal ） 。 该期刊发表有关癌症研究和治疗所有方面的文章，包括但不限于分子生物学、遗传学、病理生理学、流行病学、临床干预、对照试验、癌症患者的诊断和治疗、 治疗学、药理学和药物递送，以及癌症手术技术等主题。该期刊欢迎多种类型的稿件，包括 original research、review、systematic review、meta-analysis、 study protocols 以及 Letters to the Editor， original research 稿件可涵盖实验室、动物或人类/临床研究的各个阶段。 该期刊目前 影响因子 （IF） 为 1.9 ，根据实时影响因子预测， 该期刊将在今年 6 月份更新的影响因子中达到 2.5 分 。 该期刊现在中国 诚邀投稿 ，出版社官方特别推出 投稿福利：如您近期有适合的稿件投稿，欢迎 扫描下方二维码 填写信息 ，申请获取 APC 9 折优惠码 ...

Industry Overview - Business services providers are facing increased competition from AI-driven companies, resulting in a limited industry gain of 15.4% over the past six months, which is lower than the S&P 500's 18.6% increase [1] Company Summaries Wiley (WLY) - Wiley has a market capitalization of $1.94 billion and is a global academic publisher offering scientific journals, books, digital courseware, and knowledge solutions [3] - The stock price of Wiley is $36.80, reflecting a valuation ratio of 5.4x forward EV-to-EBITDA [5] ICF International (ICFI) - ICF International has a market capitalization of $1.50 billion and provides consulting services and technology solutions across various sectors including energy, health, environment, and security [6] - The stock price of ICF International is $81.69, trading at 12x forward P/E [8] Cisco (CSCO) - Cisco has a market capitalization of $279.9 billion and specializes in networking equipment, security solutions, and collaboration tools [9] - Cisco's sales have declined by 1.9% annually over the last five years, indicating unfavorable market trends [10] - Earnings per share for Cisco have decreased by 1.3% annually over the past two years, raising concerns about long-term stock price performance [10] - The company's free cash flow margin has decreased by 7.3 percentage points, indicating increased capital intensity [10] - Cisco's sales pipeline shows a projected sales decline of 2.6% for the next 12 months, suggesting a challenging demand environment ahead [11] - Low returns on capital highlight management's difficulties in effective fund allocation [11]